je.st
news
Tag: study drug
Study shows Glaxo heart drug which failed trial has potential benefit
2014-03-31 04:42:20| Biotech - Topix.net
The results presented at the American College of Cardiology scientific meeting in Washington provided a glimmer of hope that the medicine may have value.
Tags: study
shows
heart
potential
Study finds that drug labelling change may add $4bn to US health care costs
2014-02-07 01:00:00| Packaging Gateway
The Food and Drug Administration's (FDA) recently proposed regulation affecting generic drug labelling may result in an estimated $4bn in additional US health care costs a year, according to an analysis by economic consulting firm Matrix Global Advis
New Study Shows the Rate of Drug Approvals Lower than Previously Reported
2014-01-09 06:00:00| Industrial Newsroom - All News for Today
Nature Biotechnology has published peer-reviewed paper co-authored by BIO Industry Analysis and BioMedTracker, highlighting results of a study showing that overall success rate for drugs moving through clinical trials to FDA approval from late 2003 to the end of 2011 is near 1 in 10, while reports from earlier years showed rate of drug approvals to be 1 in 5 to 1 in 6. Study also shows that large molecule drugs are twice as successful in gaining approval compared to small molecule drugs. This story is related to the following:Trade Associations
GSK, Prosensa muscular dystrophy drug misses study goal
2013-09-20 17:19:30| Biotech - Topix.net
An experimental drug for Duchenne muscular dystrophy from GlaxoSmithKline and Prosensa failed to meet its goal in a late-stage clinical trial, sending shares in Prosensa tumbling 75 percent in pre-market trade.
Tags: study
goal
drug
muscular
Daiichi Sankyo Enters Clot Drug Race With Edoxaban Study Success
2013-09-01 22:41:19| Food - Topix.net
Daiichi Sankyo Co.' s experimental blood thinner edoxaban was found to be as effective and safer than standard treatment warfarin in a study that clears the way for the Japanese company to compete with drugmakers including Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Co.